top of page
  • White Facebook Icon
  • White Twitter Icon
Search

Divestment

  • Jan 4, 2023
  • 1 min read

Updated: Jan 12, 2023

Scope law advises an institutional investor in its divestment in connection with Biognosys AG’s strategic partnership with Bruker Corporation.


Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a majority-ownership investment in the ETH spin-off Biognosys. Financial details were not disclosed. Scope law’s client has, together with other investors, sold its shares to Bruker in a secondary transaction, and Bruker will make new primary investments in Biognosys.


 
 
 

Recent Posts

See All
Ranking

For the fifth consecutive year, Scope Law has been ranked as one of the top Swiss law firms by the renowned business magazines BILANZ and PME. We are very pleased to be included in the ranking again.

 
 
 
Financing Round

Scope Law advises Amenti AG in another successfully closed seven-digit financing round. Amenti is an innovative real estate technology (PropTech) startup, incorporated in Zurich in 2018 with the aim o

 
 
 
Financing Round

Scope Law advised CMT Digital , a US-based early-stage web3 venture firm, as lead investor in the USD 30 million strategic funding round of STS Digital AG , Zug, Switzerland, the holding company of a

 
 
 

Comments

bottom of page